Tuesday, August 17, 2021

GSK-CureVac's 2nd Covid vaccine shows better immune response

CV2CoV has higher neutralising capacity against a range of variants, including the Beta, Delta and Lambda variant and the original virus strain, the company said in a statement on Monday.

from Zee News :Zee News - Health https://ift.tt/3yWzqNs
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

New study shows injections control HIV better than daily medication

A UCL-led Lancet study showed eight-weekly HIV injections suppressed the virus far more effectively (99% success) than daily pills (94%) in...